Saltoglu, N. Et Al. 2010. Piperacillin/tazobactam versus imipenem/cilastatin for severe diabetic foot infections: a prospective, randomized clinical trial in a university hospital. CLINICAL MICROBIOLOGY AND INFECTION , vol.16, no.8 , 1252-1257.

Saltoglu, N., DALKIRAN, A., Tetiker, T., BAYRAM, H., TAŞOVA, Y., DALAY, C., ... SERT, M.(2010). Piperacillin/tazobactam versus imipenem/cilastatin for severe diabetic foot infections: a prospective, randomized clinical trial in a university hospital. CLINICAL MICROBIOLOGY AND INFECTION , vol.16, no.8, 1252-1257.

Saltoglu, BEKİR Et Al. "Piperacillin/tazobactam versus imipenem/cilastatin for severe diabetic foot infections: a prospective, randomized clinical trial in a university hospital," CLINICAL MICROBIOLOGY AND INFECTION , vol.16, no.8, 1252-1257, 2010

Saltoglu, BEKİR T. Et Al. "Piperacillin/tazobactam versus imipenem/cilastatin for severe diabetic foot infections: a prospective, randomized clinical trial in a university hospital." CLINICAL MICROBIOLOGY AND INFECTION , vol.16, no.8, pp.1252-1257, 2010

Saltoglu, N. Et Al. (2010) . "Piperacillin/tazobactam versus imipenem/cilastatin for severe diabetic foot infections: a prospective, randomized clinical trial in a university hospital." CLINICAL MICROBIOLOGY AND INFECTION , vol.16, no.8, pp.1252-1257.

@article{article, author={BEKİR TAMER TETİKER Et Al. }, title={Piperacillin/tazobactam versus imipenem/cilastatin for severe diabetic foot infections: a prospective, randomized clinical trial in a university hospital}, journal={CLINICAL MICROBIOLOGY AND INFECTION}, year=2010, pages={1252-1257} }